| Product Name | FSH ELISA kit (Rat) |
|---|---|
| Description | This assay has high sensitivity and excellent specificity for detection of Follicle Stimulating Hormone (FSH). No significant cross-reactivity or interference between Follicle Stimulating Hormone (FSH) and analogues was observed. |
| Method | Competitive |
| Detection Range | 2.47-200ng/mL |
| Sensitivity | 0.94ng/mL |
| Target | FSH |
| Specificity | This assay has high sensitivity and excellent specificity for detection of Follicle Stimulating Hormone (FSH). No significant cross-reactivity or interference between Follicle Stimulating Hormone (FSH) and analogues was observed. |
| Reactivity | Rat |
| Sample Types | Serum, Plasma And Other Biological Fluids |
| Reconstitution | 1.Prepare all reagents, samples and standards; 2.Add 50uL standard or sample to each well. And then add 50uL prepared Detection Reagent A immediately. Shake and mix.Incubate 1 hour at 37℃; 3.Aspirate and wash 3 times; 4.Add 100uL prepared Detection Reagent B.Incubate 30 minutes at 37℃; 5.Aspirate and wash 5 times; 6.Add 90uL Substrate Solution.Incubate 10-20 minutes at 37℃; 7.Add 50uL Stop Solution.Read at 450 nm immediately. |
| Storage | 4°C for 1 month/ -20°C for long-term(within shelf life) |
| Notes | Colormetric |
| References | Studies of the pharmacology of 17α-ethynyl-androst-5-ene-3β,7β,17β-triol, a synthetic anti-inflammatory androstene ;Protective role of Hibiscus sabdariffa calyx extract against streptozotocin induced sperm damage in diabetic rats;Central effects of camphor on GnRH and sexual hormones in male rat;Effects of Tadalafil on Hemorrhagic Cystitis and Testicular Dysfunction Induced by Cyclophosphamide in Rats;The effects of long-term exposure to a 2450 MHz electromagnetic field on growth and pubertal development in female Wistar rats;Piper longum hexane fraction induces infertility by modulation of inflammatory mediators and gonadotropin insufficiency in female rats;Quercetin supplementation restores testicular function and augments germ cell survival in the estrogenized rats;Protective effects of Eugenia jambolana extract versus N-acetyl cysteine against cisplatin-induced damage in rat testis;Perfluorooctane sulfonate effects on the reproductive axis in adult male rats;Apoptosis in testicular tissue of rats after vasectomy: evaluation of eNOS, iNOS immunoreactivities and the effects of ozone therapy;Mechanistic Study on Triptorelin Action in Protecting From 5-FU-Induced Ovarian Damage in Rats;The effect of R-(-)-deprenyl administration on reproductive parameters of rat males;Dose‐and time‐dependent effects of Garcinia kola seed extract on sexual behaviour and reproductive parameters in male Wistar rats;Simvastatin decreases steroid production in the H295R cell line and decreases steroids and FSH in female rats;Sex-specific prenatal stress effects on the rat reproductive axis and adrenal gland structure;Maternal High-Fat Diet Induced Loss of Fetal Oocytes Is Associated with Compromised Follicle Growth in Adult Rat Offspring;Dose- and time-dependent effects of Garcinia kola seed extract on sexual behaviour and reproductiveparameters in male Wistar rats.;Molecular characterization of insulin resistance and glycolytic metabolism in the rat uterus;Metformin Ameliorates Uterine Defects in a Rat Model of Polycystic Ovary Syndrome.;Effects of treatment with Hypoxis hemerocallidea extract on sexual behaviour and reproductiveparameters in male rats.;Maternal High-Fat Diet-Induced Loss of Fetal Oocytes Is Associated with Compromised Follicle Growth in Adult Rat Offspring.;Impact of uteroplacental insufficiency on postnatal rat male gonad.;Beneficial effects of Heqi san on rat model of polycystic ovary syndrome through the PI3K/AKT pathway;The role of mesenchymal stem cells in chemotherapy-induced gonadotoxicity;Maternal nutrient restriction impairs young adult offspring ovarian signaling resulting in reproductive dysfunction and follicle loss;DHEA-induced ovarian hyperfibrosis is mediated by TGF-β signaling pathway;Eicosapentaenoic Acid Improves Polycystic Ovary Syndrome in Rats via Sterol Regulatory Element-Binding Protein 1 (SREBP-1)/Toll-Like Receptor 4 (TLR4) …;Palladium nanoparticle effects on endocrine reproductive system of female rats;Protective Effects of Uncultured Adipose‐Derived Stromal Vascular Fraction on Testicular Injury Induced by Torsion‐Detorsion in Rats;Uterine progesterone signaling is a target for metformin therapy in polycystic ovary syndrome;G-CSF-mobilized Peripheral Blood Mononuclear Cells Combined with Platelet-rich Plasma Accelerates Restoration of Ovarian Function in Cyclophosphamide …;The therapeutic potential of amifostine on cyclophosphamide-induced testicular dysfunction in rats: An experimental study.;Sperm parameters quality and reproductive effects of methanolic extract of Alchornea cordifolia leaves on senescent male rats;Baicalin ameliorates polycystic ovary syndrome through AMP-activated protein kinase;Effect of DHT-Induced Hyperandrogenism on the Pro-Inflammatory Cytokines in a Rat Model of Polycystic Ovary Morphology;Novel mechanisms underlying anti-polycystic ovary like syndrome effects of electroacupuncture in rats: suppressing SREBP1 to mitigate insulin resistance …;MiRNAs expression profiling of rat ovaries displaying PCOS with insulin resistance;Composition of Royal Jelly (RJ) and Its Anti-Androgenic Effect on Reproductive Parameters in a Polycystic Ovarian Syndrome (PCOS) Animal Model;N, N-Dimethylacetamide, an FDA approved excipient, acts post-meiotically to impair spermatogenesis and cause infertility in rats;Pathophysiological Changes in Female Rats with Estrous Cycle Disorder Induced by Long-Term Heat Stress;Therapeutic effects of organic zinc on reproductive hormones, insulin resistance and mTOR expression as a novel component in a rat model of PCOS;Hemin Ameliorated Letrozole-Induced Polycystic Ovary Syndrome: A Forward Step for Better Management;Drug-Herb Interaction Between Selective Estrogen Receptor Modulators and Estrogenic Herbal Medicine Er-Xian Decoction in Bone in Vivo and in Vitro;Zihuai recipe alleviates cyclophosphamide-induced diminished ovarian reserve via suppressing PI3K/AKT-mediated apoptosis;The Effects of Zinc Methionine on Reproductive and Thyroid Hormones in Rats with Polycystic Ovarian Syndrome;Diabetes Type 1 Negatively Influences Leydig Cell Function in Rats, Which is Partially Reversible By Insulin Treatment;Water extract of Er-xian decoction selectively exerts estrogenic activities and interacts with SERMs in estrogen-sensitive tissues;Exposure to the bromodomain inhibitor N-methyl pyrrolidone blocks spermatogenesis in a hormonal and non-hormonal fashion;Comparison of ovarian striation and ovarian fragmentation in a rat model of ovarian insufficiency;Endothelial dysfunction after androgen deprivation therapy and the possible underlying mechanisms;Activated Human Umbilical Cord Blood Platelet-Rich Plasma Enhances the Beneficial Effects of Human Umbilical Cord Mesenchymal Stem Cells in …;Superior effect of broccoli methanolic extract on control of oxidative damage of sperm cryopreservation and reproductive performance in rats: A comparison with …;G-CSF-mobilized Peripheral Blood Mononuclear Cells Combined with Platelet-rich Plasma Restored the Ovarian Function of aged rats via angiogenesis and …;Drug-free in vitro activation combined 3D-bioprinted adipose-derived stem cells restore ovarian function of premature ovarian insufficiency;A promising animal model for Polycystic Ovary Syndrome: Borderline Hypertensive Rats; |
| Supplier | Cloud Clone |
PROTOCOLS:
CEA830Ra All Research Products are sold for laboratory RESEARCH USE ONLY and ARE NOT TO BE USED FOR HUMAN OR ANIMAL THERAPEUTIC OR DIAGNOSTIC APPLICATIONS. The information presented is believed to be accurate; however, said information and products are offered without warranty or guarantee since the ultimate conditions of use and the variability of the materials treated are beyond our control. Nothing disclosed herein is to be construed as a recommendation to use our products in violation of any patents. ARP American Research Products, Inc. does not submit its products for regulatory review by any government body or other organization, and we do not validate them for clinical, therapeutic or diagnostic use, or for safety and effectiveness. You are solely responsible for making sure that the way you use the products complies with applicable laws, regulations and governmental policies and for obtaining all necessary approvals, intellectual property rights, licenses and permissions that you may need related to your use. Under no circumstances shall ARP American Research Products, Inc. be liable for damages, whether consequential, compensatory, incidental or special, strict liability or negligence, breach of warranty or any other theory arising out of the use of the products available from ARP American Research Products, Inc. Nothing contained herein warrants that the use of the products will not infringe on the claims of any patents covering the product itself or the use thereof in combination with other products or in the operation of any process. ARP American Research Products, Inc. disclaims any and all representations or warranties of any kind whatsoever, express or implied, including without limitation any implied warranties of merchantability or fitness for a particular purpose, of non-infringement, or regarding results obtained through the use of any product, whether arising from a statute or otherwise in law or from a course of performance, dealing or usage of trade.
